Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

A Phase II Study of THP-COP (pirarubicin, cyclophosphamide, vincristine and prednisolone) in Patients with Newly Diagnosed Advanced Peripheral T-Cell Lymphoma: THP-3 Study of Japan Hematopoietic Malignancy Clinical Study Group (HMCSG)

Michinori Ogura, MD PhD, Ken Ohmachi, MD, Ritsuro Suzuki, MD PhD, Yoshiko Atsuta, MD PhD, Tatsuya Ito, MD, Kazuma Ohyashiki, MD, Shingo Yano, MD PhD, Michihiro Hidaka, MD PhD, Kiyoshi Ando, MD PhD, Noriko Fukuhara, MD PhD, Yoshihisa Morishita, MD PhD, Takayo Suzuki, MD PhD, Kunihiro Tsukasaki, MD PhD, Naoki Kobayashi, MD PhD, Kenji Tsukamoto, MD, Yukiyasu Ozawa, MD PhD, Tomomitsu Hotta, MD PhD, Tomohiro Kinoshita, MD PhD

Blood (2017) 130 (Supplement 1): 2789.

https://doi.org/10.1182/blood.V130.Suppl_1.2789.2789

Published: 2017

Journal Articles

A Serum Biomarker Panel Composed of C-Reactive Protein and Albumin Could Predict the Transplant-Related Complications and the Outcomes of Allogeneic Hematopoietic Cell Transplantation

Kazutaka Ozeki, MD PhD, Yukiyasu Ozawa, MD, Naomi Kawashima, MD, Yusuke Yamaga, MD, Yoshitaka Adachi, MD, Koji Umemura, MD, Shoichiro Okazaki, MD, Akio Kohno, MD PhD, Koichi Miyamura, MD PhD, Yoshihisa Morishita, MD PhD

Blood (2015) 126 (23): 3147.

https://doi.org/10.1182/blood.V126.23.3147.3147

Published: 2015

Journal Articles

A Plasma Marker Panel Diagnostic for Dismal Transplant-Related Complications

Kazutaka Ozeki, MD PhD, Akio Kohno, MD PhD, Yohei Yamaguchi, MD, Koji Umemura, MD, Yoshitaka Adachi, MD, Koichi Watamoto, MD PhD, Yoshihisa Morishita, MD PhD

Blood (2014) 124 (21): 1159.

https://doi.org/10.1182/blood.V124.21.1159.1159

Published: 2014

Journal Articles

Predictive and Diagnostic Value Of Circulating Angiopoietin-2 For Transplant-Related Complications

Yoshihisa Morishita, MD, PhD, Norihiro Ueda, MD, Dai Chihara, MD, PhD, Shotaro Tatekawa, MD, Kazutaka Ozeki, MD, PhD, Koichi Watamoto, MD, Akio Kohno, MD, PhD

Blood (2013) 122 (21): 3279.

https://doi.org/10.1182/blood.V122.21.3279.3279

Published: 2013

Journal Articles

Optimization of Fludarabine + Melphalan Conditioning for Marrow Transplantation From Unrelated Donors for Patients with Hematopoietic Malignancies: A Prospective Dose-Finding Trial Using Modified Continual Reassessment Method.

Seitaro Terakura, MD, PhD, Masashi Sawa, MD, PhD, Haruhiko Ohashi, MD, PhD, Tomonori Kato, MD, Satoshi Nishiwaki, MD, Nobuhiko Imahashi, MD, Makoto Murata, MD, PhD, Koichi Miyamura, MD, PhD, Yoshiko Atsuta, MD, PhD, Ritsuro Suzuki, MD, PhD, Tomoki Naoe, MD, PhD, Tatsuya Ito, MD, PhD, Yoshihisa Morishita, MD, PhD

Blood (2009) 114 (22): 2273.

https://doi.org/10.1182/blood.V114.22.2273.2273

Published: 2009

Journal Articles

Favorable Impact of Short Term Methotrexate on Early Immune Reaction and Non-Relapse Mortality in Umbilical Cord Blood Transplantation for Adult Patients.

Masato Watanabe, MD, Hiroto Narimatsu, MD, Seitaro Terakura, MD, Keitaro Matsuo, MD, Taku Oba, MD, Masanobu Kasai, MD, Hiroatsu Iida, MD, Motohiro Hamaguchi, MD, Akio Kohno, MD, Makoto Murata, MD, Masashi Sawa, MD, Koichi Miyamura, MD, Yoshihisa Morishita, MD, Nagoya BMT Group

Blood (2006) 108 (11): 5297.

https://doi.org/10.1182/blood.V108.11.5297.5297

Published: 2006

Journal Articles

Chronic Graft-Versus-Host Disease after Allogenaic Bone Marrow Transplantation in Japan: Identification of Risk Factors and Prognostication.

Yoshiko Atsuta, MD, Ritsuro Suzuki, MD, Kazuhito Yamamoto, MD, Seitaro Terakura, MD, Hiroatsu Iida, MD, Akio Kohno, MD, Tomoki Naoe, MD, Hiroshi Sao, MD, Yoshihisa Kodera, MD, Yasuo Morishima, MD, Nobuyuki Hamajima, MD, Yoshihisa Morishita, MD

Blood (2005) 106 (11): 1808.

https://doi.org/10.1182/blood.V106.11.1808.1808

Published: 2005

Journal Articles

Overexpression of Cyclin E in Acute Myelogenous Leukemia

Hiroatsu Iida, Masayuki Towatari, Mitsune Tanimoto, Yoshihisa Morishita, Yoshihisa Kodera, Hidehiko Saito

Blood (1997) 90 (9): 3707–3713.

https://doi.org/10.1182/blood.V90.9.3707

Published: 1997

NARROW

A Phase II Study of THP-COP (pirarubicin, cyclophosphamide, vincristine and prednisolone) in Patients with Newly Diagnosed Advanced Peripheral T-Cell Lymphoma: THP-3 Study of Japan Hematopoietic Malignancy Clinical Study Group (HMCSG)

A Serum Biomarker Panel Composed of C-Reactive Protein and Albumin Could Predict the Transplant-Related Complications and the Outcomes of Allogeneic Hematopoietic Cell Transplantation

A Plasma Marker Panel Diagnostic for Dismal Transplant-Related Complications

Predictive and Diagnostic Value Of Circulating Angiopoietin-2 For Transplant-Related Complications

Optimization of Fludarabine + Melphalan Conditioning for Marrow Transplantation From Unrelated Donors for Patients with Hematopoietic Malignancies: A Prospective Dose-Finding Trial Using Modified Continual Reassessment Method.

Favorable Impact of Short Term Methotrexate on Early Immune Reaction and Non-Relapse Mortality in Umbilical Cord Blood Transplantation for Adult Patients.

Chronic Graft-Versus-Host Disease after Allogenaic Bone Marrow Transplantation in Japan: Identification of Risk Factors and Prognostication.

Overexpression of Cyclin E in Acute Myelogenous Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only